Venture Market News for October 25, 2018
- Western Uranium & Vanadium Announces Plan to Re-Open the Sunday Mine Complex
TORONTO and NUCLA, Colo., Oct. 25, 2018 (GLOBE NEWSWIRE) -- Western Uranium & Vanadium Corp. (CSE: WUC) (OTCQX: WSTRF) (“Western” or the ”Company”) announces its intention to re-open the Sunday Mine Complex (“SMC”). Western is commencing this program with the goals of upgrading the vanadium resource and monetizing these already significant vanadium resource holdings.
- Cannabis Lozenge Patent Issued to Cannabis Sativa, Inc. by US Patent & Trademark Office
Cannabis Sativa, Inc. (OTCQB: CBDS)is pleased to announce that on October 23, 2018, the United States Patent Office issued US Patent number 10105343 titled Cannabis based compositions and methods of treating hypertension to Cannabis Sativa. The marijuana lozenge invention relates to aCannabis-based pharmaceutical composition for the treatment of hypertensive disorders by submucosal delivery comprising a pharmaceutically acceptable base and an effective amount of at least one cannabinoid or endocannabinoid containing extract of a cloned hybrid of the plantCannabis sativa,subspeciessativaandCannabis sativa,subspeciesindicaof the CTSX-ISS lineage.
- MedMen Reports Fourth Quarter and Fiscal Year 2018 Financial Results
MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF) (FSE: A2JM6N), today released its consolidated financial results for the fourth quarter and fiscal year 2018 ended June 30, 2018. All financial information in this press release is reported in US dollars, unless otherwise indicated.
- Jones Soda Sets Third Quarter 2018 Conference Call for Thursday, November 8, 2018, at 4:30 p.m. ET
SEATTLE, Oct. 25, 2018 (GLOBE NEWSWIRE) -- Jones Soda Co. (the “Company”) (OTCQB: JSDA), a leader in the craft soda category and known for its unique branding and innovative marketing, will hold a conference call on Thursday, November 8, 2018, at 4:30 p.m. Eastern time to discuss its financial results for the third quarter ended September 30, 2018. The financial results will be reported in a press release prior to the conference call.
- Cannabics Pharmaceuticals Granted Patent in South Africa for Its Personalized Cannabinoid Based Diagnostics
TEL AVIV, Israel and BETHESDA, Maryland, Oct. 25, 2018 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced today that it has been granted its patent for its core technology by the South Africa Patent Office. Following the patent's approval in Israel in September 2018, this patent encompasses the systems and methods required to produce data on the interaction between different cannabinoids and cancer cells. This technology enables screening the effects of a multitude of compounds derived from the cannabis plant on cancer cell lines and biopsies. The technology will facilitate the development of more accurate cannabinoid compounds designated for specific cancers and specific genetic profile of patients, and at the same time will serve as a source for supportive data for cannabinoid-based treatments.
Connect with 24/7 Market News on social media:
About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN provides comprehensive corporate communications resources and tools to engage the investment community.
24/7 Market News (24/7MN) is a third party publisher and news dissemination service provider that produces regular sponsored and non-sponsored reports, articles, stock market blogs, and newsletters covering equities listed on the NYSE, NASDAQ and micro-cap exchanges. 24/7MN holds no investment licenses and is NOT a financial advisory firm, investment adviser, analyst, or broker-dealer and does not undertake any activities that would require such registration. 24/7MN's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities.
The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and based on publicly available information which is believed to be reliable. 24/7MN makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. 24/7MN and/or its affiliates are not responsible for any gains or losses that result from the opinions expressed and are not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks.
For further information on 24/7 Market News, please go to www.247marketnews.com
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan," or "planned," "will," or "should," "expected," "anticipates," "draft," "eventually," or "projected." You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and 24/7MN undertakes no obligation to update such statements
24/7 Market News